ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,860.00
0.49%
S&P ASX All Technology
3,102.60
0.47%
Brent Oil
79.885
0.01%
US Dollar vs AUD
1.49788
-0.10%
Bitcoin
71,193.49
0.61%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. 23andMe Holding Company (ME)

  7. 23andMe Holding Company (ME) News

ME

23andMe (ME)

23andMe Holding Company
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ME
DateTimeSourceHeadlineSymbolCompany
05/06/202421:00GlobeNewswire Inc.23andMe Launches New Genetic Report on Bipolar DisorderNASDAQ:ME23andMe Holding Company
04/06/202421:00GlobeNewswire Inc.23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black CommunityNASDAQ:ME23andMe Holding Company
03/06/202422:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
03/06/202422:00GlobeNewswire Inc.23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual MeetingNASDAQ:ME23andMe Holding Company
29/05/202422:00GlobeNewswire Inc.Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and historyNASDAQ:ME23andMe Holding Company
25/05/202406:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
24/05/202407:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
24/05/202406:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
24/05/202406:05GlobeNewswire Inc.23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial ResultsNASDAQ:ME23andMe Holding Company
22/05/202406:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
22/05/202406:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
14/05/202421:00GlobeNewswire Inc.Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros PharmaceuticalsNASDAQ:ME23andMe Holding Company
11/05/202406:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
10/05/202406:50GlobeNewswire Inc.23andMe to Report Q4 and Full Year FY2024 Financial ResultsNASDAQ:ME23andMe Holding Company
01/05/202401:00Business WirePotter Handy Law Firm Represents Nearly 5,000 Clients in 23andMe Data Breach CaseNASDAQ:ME23andMe Holding Company
25/04/202406:05GlobeNewswire Inc.23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:ME23andMe Holding Company
18/04/202422:00GlobeNewswire Inc.23andMe announces CEO’s intention to pursue a potential take-privateNASDAQ:ME23andMe Holding Company
06/04/202407:05GlobeNewswire Inc.23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:ME23andMe Holding Company
20/03/202422:30GlobeNewswire Inc.23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6NASDAQ:ME23andMe Holding Company
19/03/202423:00GlobeNewswire Inc.23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years AgoNASDAQ:ME23andMe Holding Company
06/03/202423:30GlobeNewswire Inc.23andMe Launches New Genetic Reports on Common Forms of CancerNASDAQ:ME23andMe Holding Company
06/03/202408:30GlobeNewswire Inc.23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:ME23andMe Holding Company
22/02/202408:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ME23andMe Holding Company
08/02/202408:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ME23andMe Holding Company
08/02/202408:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
08/02/202408:01GlobeNewswire Inc.23andMe Reports Third Quarter Fiscal 2024 Financial ResultsNASDAQ:ME23andMe Holding Company
06/02/202423:00Business WireMoneta Gold and Nighthawk Gold Complete At-Market Merger to form STLLR Gold Inc.NASDAQ:ME23andMe Holding Company
31/01/202423:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ME23andMe Holding Company
31/01/202414:12GlobeNewswire Inc.23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernayNASDAQ:ME23andMe Holding Company
31/01/202409:00Business WireNighthawk Gold Obtains Final Court Order for the Proposed ArrangementNASDAQ:ME23andMe Holding Company
 Showing the most relevant articles for your search:NASDAQ:ME

Your Recent History

ASX
XTO
S&P ASX 100
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
BTCUSD
Bitcoin
ASX
AMP
AMP
ASX
SUN
Suncorp
NYSE
JPM
JP Morgan Chase
FX
AUDCAD
AUD vs CAD
ASX
WPL
Woodside Petroleum
NYSE
MCD
McDonalds
NYSE
NKE
Nike
FX
AUDUSD
AUD vs US Dollar
ASX
CBA
Commonwealth Bank Of Aus...
ASX
MQG
Macquarie
ASX
ORG
Origin Energy
ASX
NCM
Newcrest Mining
NYSE
VZ
Verizon Communications
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved